AstraZeneca
Update in progressAZN (NYSE)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDrug Manufacturers - General
AstraZeneca PLC is a biopharmaceutical company focused on discovering, developing, manufacturing, and selling prescription medicines. It offers a broad portfolio across oncology, cardiovascular, renal and metabolism, respiratory and immunology, vaccines, and rare diseases. The company serves primary and specialty care through distributors and local offices worldwide. Headquartered in Cambridge, UK, it was formerly Zeneca and was incorporated in 1992. It has strategic research collaborations with Tempus, Pathos, and CSPC.
Company score
- Sentiment
- 2.20
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 1.53
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 2.09
- Governance
- -0.44
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 1.05
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 1.62
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNYSE (NYQ)
- LocationUnited Kingdom
- CEOMr. Pascal Claude Roland Soriot D.V.M., M.B.A.
- Founded1992
- Employees96,100
- Websitewww.astrazeneca.com
Identifiers
- ISINUS0463531089
- LEIPY6ZZQWO2IZFZC3IOL08
- CUSIP046353108